Pace Ventures

Vema Hydrogen is a trailblazing company specializing in clean hydrogen production. It tackles the global challenge of decarbonization by generating hydrogen through geologic stimulation, offering a clean and cost-effective alternative to traditional methods. The company employs advanced numerical simulations, geochemical analysis, and multiphase flow studies to optimize hydrogen production. It also identifies and tests suitable geological locations for pilot projects, obtains necessary permits, and optimizes catalyst use to enhance efficiency.

Dunia Innovations is pioneering the development of the world's first self-driving laboratory dedicated to electrocatalytic CO2 utilization. The company aims to facilitate the energy transition by addressing challenges in scalable carbon utilization, thereby fostering a circular carbon economy. By transforming carbon dioxide into valuable chemicals and fuels, Dunia Innovations helps businesses understand their carbon footprints and actively contributes to achieving net zero emissions. Through its innovative approach, the company seeks to significantly accelerate catalyst research and optimize processes for effective carbon management.

Turnover Labs develops innovative carbon capture technology designed to transform industrial emissions into valuable products. This process enables businesses to lower production costs and achieve carbon neutrality.

AI driven SaaS platform for smarter mobility emission management for fleet owners, operators and customers.

Neurable develops AI-powered neurotechnology for brain-computer interfaces. Its platform translates brain signals into actionable inputs, enabling users to interact with software and devices using only their thoughts.

Virtonomy GmbH is a Munich-based company that specializes in providing clinical trial services using virtual human, sheep, pig, and calf models. Founded in 2019, Virtonomy offers a platform that integrates digital twin models, AI, multi-physics simulations, and predictive analytics to enhance the development and evaluation of medical devices. The company delivers services such as anatomy studies, virtual fittings, pre-operative planning, and visualization through detailed image analysis and three-dimensional anatomical models. By enabling medical device manufacturers to optimize designs, reduce risks associated with anatomical variability, and develop patient-specific implants, Virtonomy facilitates a streamlined product development process. This approach not only shortens development timelines but also minimizes costs and risks linked to traditional clinical trials, allowing for safer and more efficient testing in a virtual environment.

Founded in 2015, Aerones specializes in robotic technology for wind turbine blade maintenance services. Headquartered in San Jose, California, the company offers automated inspection, cleaning, coating, and repair operations to maximize asset efficiency and reduce downtime.

Founded in 2015, Aerones specializes in robotic technology for wind turbine blade maintenance services. Headquartered in San Jose, California, the company offers automated inspection, cleaning, coating, and repair operations to maximize asset efficiency and reduce downtime.

Celeris Therapeutics is an AI-first drug discovery company that focuses on developing proximity-inducing compounds (PICs), particularly PIC degraders, to address high unmet medical needs in diseases like Parkinson's and various cancers. The company has created the Celeris One platform, which utilizes structure-based geometric deep learning to enhance the design and development of degraders by prioritizing specific E3 ligases, designing effective linkers, and selecting optimal compounds for synthesis. Additionally, Celeris Therapeutics operates an in-house automated laboratory that facilitates rapid generation of experimental data for further optimization. The company collaborates with pharmaceutical and biotech firms to discover and develop small-molecule degrader therapies across multiple therapeutic areas, while also advancing its own internal drug pipeline. Celeris Therapeutics maintains offices in Menlo Park, California, and Graz, Austria.